|
Name |
Areas of Special Interest |
|
Ronald N. Goldberg, MD, Chief |
Care of the low birth weight infant, persistent pulmonary hypertension, sepsis and septic shock, and congenital diaphragmatic hernia. |
|
Convalescent care of chronically ill neonates and the acute care of mild to moderately ill newborns. | |
|
Prematurity, bronchopulmonary dysplasia, and neonatal ventilation. | |
|
Critically ill newborns, newborns with congenital malformations, severe respiratory failure, ECMO, high frequency ventilation, and nitric oxide. | |
|
High-risk neonatal and transitional care of the newborn. Prenatal and neonatal palliative care. Performance improvement. | |
|
Neonatal care. | |
|
Optimizing care for newborns with evidenced-based practice. Special interests include infectious diseases in low birth weight infants, perinatal asphyxia, congenital diaphragmatic hernia, and the genomic approach to neonatal diseases. | |
|
Medical informatics, computerized patient safety initiatives, quality improvement metrics, electronic research data exchange, medical data standards and interoperability, neonatal critical care, CPOE, and electronic medical records. | |
| Neonatal intensive care and neuro-developmental follow-up of high risk infants. | |
|
Intensive and transitional care of the ill newborn, neonatal skin, skin care and breast-feeding of the preterm, and medical education. | |
|
Prevention of neurodevelopmental inpairment in extremely premature infants; pediatric pharmacology; non-invasive monitoring of the neonate. | |
|
Transitional Care Nursery, convalescent and follow-up care of high risk infants, gastroesophageal reflux. | |
|
Care of the critically ill neonate with special interest in respiratory disorders. | |
| Nosocomial infections in preterm neonates, drug safety and efficacy in neonates | |
|
High risk neonatal care, financial process analysis. | |
|
High risk neonatal care, developmental care.
| |
|
Care of premature and critically ill infants; neonatal sepsis; immunology and immunomodulation; physician teaching and development. |
|
Name |
Areas of Special Interest |
| Richard L. Auten, MD | Mechanisms by which oxidative stress disrupts postnatal lung development in premature newborns. |
|
Palliative care. | |
|
Role of the macrophage in alveolar simplification as a feature of bronchopulmonary dysplasia. | |
|
Use of cord blood therapy for perinatal asphyxia, use of genomic studies to diagnose and guide neonatal therapy. | |
|
Use of medical informatics, computerized patient safety initiatives. | |
|
Perinatal asphyxia, use of stem cell/cord blood therapy for perinatal asphyxia. | |
| Mary Hutson, PhD |
Cardiovascular defects, especially those related to the arterial pole. |
|
Etiology and pathogenesis of congential heart defects. | |
| Neurodevelopmental research of neural stem cells. | |
|
Diagnosis and management of gastroesophageal reflux. | |
| Nosocomial infections, neonatal candidiasis, neonatal pharmacology | |
|
Health care economics.
|
|
Name |
Position |
|
Medical Director | |
| Kimberley Fisher, PhD, FNP-BC, IBCLC |
Director of Operations
|
|
Name |
Position |
|
Malissa Dunn, RRT |
Clinical Research Nurse |
|
Katherine Foy, RN |
Clinical Research Coordinator, Neonatal Research Network |
|
Sandra Grimes, RN, BSN |
Coordinator of Industry and Investigator Research |
| Charles Vajdl |
Clinical Trials Assistant
|
|
| |
Staff | |
| Name |
Position |
|
Jennifer McLamb |
Patient Services |
|
Emily Patterson |
Patient Services |
DHTS Web Services